1. Scrip
  2. >>Business

Interview: German Merck Set For Big "Leap" In India

 
• By Anju Ghangurde

Germany's Merck Group appears set to build on its strong showing in India. Belén Garijo, CEO of Healthcare at Merck KGAA, tells Scrip about efforts to "consumerize" the firm's primary care business, how Erbitux is the "backbone" on which the company will build its oncology presence, and plans to roll out new products including the clinical stage immune-oncology asset avelumab, in India.

Belen Garijo
Belen Garijo, CEO, Merck Healthcare

Germany's Merck KGAA appears to have put in place the key elements to catapult growth in its India business.

It has made significant investments to bring scale to its manufacturing capabilities; its healthcare business now operates under a "renewed"...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

More from Scrip